Page last updated: 2024-08-24

epigallocatechin gallate and HIV Coinfection

epigallocatechin gallate has been researched along with HIV Coinfection in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (54.55)	29.6817
2010's	5 (45.45)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ho, WZ; Li, JL; Li, XD; Liu, H; Liu, JB; Liu, MQ; Ma, TC; Wang, X; Xiao, QH; Zhou, L; Zhou, RH; Zhou, W; Zhuang, K	1
Jiang, S; Li, L; Liu, S; Lu, H; Lu, L; Oksov, Y; Pan, C; Tan, S; Tang, X	1
Nance, CL; Shearer, WT; Siwak, EB	1
Hauber, I; Hauber, J; Hohenberg, H; Holstermann, B; Hunstein, W	1
Alberte, RS; Fink, RC; Roschek, B	1
Hattori, T; Kodama, EN; Li, S	1
Basrur, V; Brender, JR; Hartman, K; Macdonald, PM; Popovych, N; Ramamoorthy, A; Soong, R; Vivekanandan, S	1
Chen, W; Jiang, F; Liu, P; Yi, K; Zhao, Y	1
Nance, CL; Shearer, WT	1
Hamza, A; Zhan, CG	1
McCormick, TG; Nance, CL; Shearer, WT; Williamson, MP	1

Reviews

2 review(s) available for epigallocatechin gallate and HIV Coinfection

Article	Year
Catechins containing a galloyl moiety as potential anti-HIV-1 compounds. Drug discovery today, 2012, Volume: 17, Issue:11-12 Topics: Anti-HIV Agents; Catechin; Drug Discovery; HIV Infections; HIV-1; Humans; Molecular Structure	2012
Is green tea good for HIV-1 infection? The Journal of allergy and clinical immunology, 2003, Volume: 112, Issue:5 Topics: Antiviral Agents; Catechin; HIV Infections; HIV-1; Humans; Phytotherapy; Plant Preparations; Tea	2003

Other Studies

9 other study(ies) available for epigallocatechin gallate and HIV Coinfection

Article	Year
Epigallocatechin-3-gallate local pre-exposure application prevents SHIV rectal infection of macaques. Mucosal immunology, 2018, Volume: 11, Issue:4 Topics: Animals; Antiviral Agents; Catechin; CD4 Antigens; Cell Movement; Disease Transmission, Infectious; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Macaca; Macrophages; Protein Binding; Risk; Sexually Transmitted Diseases, Viral; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tea	2018
Peptides derived from HIV-1 gp120 co-receptor binding domain form amyloid fibrils and enhance HIV-1 infection. FEBS letters, 2014, May-02, Volume: 588, Issue:9 Topics: Amino Acid Sequence; Amyloid; Anti-HIV Agents; Catechin; Cell Line; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Molecular Sequence Data; Peptide Fragments; Protein Interaction Domains and Motifs; Virus Internalization	2014
Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy. The Journal of allergy and clinical immunology, 2009, Volume: 123, Issue:2 Topics: Antioxidants; Apoptosis; Camellia sinensis; Catechin; CD4-Positive T-Lymphocytes; Cell Proliferation; Cell Survival; Cells, Cultured; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Macrophages	2009
The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Proceedings of the National Academy of Sciences of the United States of America, 2009, Jun-02, Volume: 106, Issue:22 Topics: Amyloid; Anti-HIV Agents; Camellia sinensis; Catechin; Cells, Cultured; HIV Infections; HIV-1; Humans; Male; Peptide Fragments; Protein Tyrosine Phosphatases; Semen	2009
HIV type-1 entry inhibitors with a new mode of action. Antiviral chemistry & chemotherapy, 2009, Volume: 19, Issue:6 Topics: Anti-HIV Agents; Binding Sites; Camellia sinensis; Catechin; Cell Line, Tumor; Cinnamomum zeylanicum; Dose-Response Relationship, Drug; Drug Discovery; Drug Synergism; Enfuvirtide; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Mass Spectrometry; Peptide Fragments; Plant Extracts; Reproducibility of Results; Sambucus; Time Factors; Virion; Virus Internalization	2009
Epigallocatechin gallate inhibits the HIV reverse transcription step. Antiviral chemistry & chemotherapy, 2011, Jul-04, Volume: 21, Issue:6 Topics: Anti-HIV Agents; Catechin; Drug Evaluation, Preclinical; Drug Synergism; HeLa Cells; HIV Infections; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Reverse Transcriptase Inhibitors; Reverse Transcription; Uracil; Zidovudine	2011
Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286). The journal of physical chemistry. B, 2012, Mar-22, Volume: 116, Issue:11 Topics: Acid Phosphatase; Amino Acid Sequence; Catechin; HIV Infections; Humans; Hydrogen-Ion Concentration; Kinetics; Microscopy, Fluorescence; Molecular Sequence Data; Protein Binding; Protein Multimerization; Protein Tyrosine Phosphatases; Serum Amyloid A Protein	2012
How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors. The journal of physical chemistry. B, 2006, Feb-16, Volume: 110, Issue:6 Topics: Anti-HIV Agents; Binding Sites; Catechin; CD4-Positive T-Lymphocytes; Computer Simulation; Drug Design; HIV Envelope Protein gp120; HIV Infections; HIV-1; Ligands; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Protein Structure, Tertiary; Stereoisomerism; Structure-Activity Relationship; Tea; Time Factors	2006
Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy. The Journal of allergy and clinical immunology, 2006, Volume: 118, Issue:6 Topics: Binding Sites; Catechin; CD4 Antigens; CD4 Immunoadhesins; Flavonoids; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Phenols; Polyphenols; Protease Inhibitors; Receptors, HIV; Tea	2006